Effect of race on cardiometabolic responses to once-weekly exenatide: insights from the Exenatide Study of Cardiovascular Event Lowering (EXSCEL)

被引：0
|
作者：
Timothy M. E. Davis
Anna Giczewska
Yuliya Lokhnygina
Robert J. Mentz
Naveed Sattar
Rury R. Holman
机构：
[1] University of Western Australia,Medical School
[2] Fremantle Hospital,Duke Clinical Research Institute
[3] Duke University School of Medicine,Institute of Cardiovascular and Medical Sciences
[4] University of Glasgow,Diabetes Trials Unit, Radcliffe Department of Medicine
[5] University of Oxford,undefined
来源：
Cardiovascular Diabetology | / 21卷
关键词：
Exenatide once weekly; Cardiovascular risk factors; Racial differences;
D O I：
暂无
中图分类号：
学科分类号：
摘要：
引用
收藏
相关论文
共 50 条
  • [1] Effect of race on cardiometabolic responses to once-weekly exenatide: insights from the Exenatide Study of Cardiovascular Event Lowering (EXSCEL)
    Davis, Timothy M. E.
    Giczewska, Anna
    Lokhnygina, Yuliya
    Mentz, Robert J.
    Sattar, Naveed
    Holman, Rury R.
    CARDIOVASCULAR DIABETOLOGY, 2022, 21 (01)
  • [2] Cardiovascular safety and efficacy of exenatide once-weekly in patients with moderate renal dysfunction in the EXenatide Study of Cardiovascular Event Lowering (EXSCEL)
    Hernandez, A. F.
    Bethel, M. A.
    Bakris, G. L.
    Merrill, P.
    Gustavson, S. M.
    Katona, B. G.
    Ohman, P.
    Lokhnygina, Y.
    Mentz, R. J.
    Holman, R. R.
    DIABETOLOGIA, 2018, 61 : S38 - S38
  • [3] Renal Outcomes in the EXenatide Study of Cardiovascular Event Lowering (EXSCEL)
    Bethel, M. Angelyn
    Mentz, Robert J.
    Merrill, Peter
    Buse, John B.
    Chan, Juliana C.
    Goodman, Shaun G.
    Iqbal, Nayyar
    Jakuboniene, Neli
    Katona, Brian G.
    Lokhnygina, Yuliya
    Lopes, Renato D.
    Maggioni, Aldo P.
    Ohman, Peter K.
    Poulter, Neil R.
    Ramachandran, Ambady
    Tankova, Tsvetalina
    Zinman, Bernard
    Hernandez, Adrian F.
    Holman, Rury R.
    DIABETES, 2018, 67
  • [4] Effect of Exenatide Once-Weekly on Clinical Outcomes in Patients With Type 2 Diabetes Mellitus and Cardiovascular Disease: Insights From the EXSCEL Trial
    Mentz, Robert J.
    Bethel, M. Angelyn
    Thompson, Vivian P.
    Lokhnygina, Yuliya
    Buse, John B.
    Chan, Julian C.
    Choi, Jasmine
    Gustavson, Stephanie M.
    Iqbal, Nayyar
    Maggioni, Aldo P.
    Marso, Steven P.
    Ohman, Peter
    Pagidipati, Neha J.
    Poulter, Neil
    Ramachandran, Ambady
    Zinman, Bernard
    Holman, Rury R.
    Hernandez, Adrian F.
    CIRCULATION, 2017, 136 (24) : E455 - E455
  • [5] Microvascular and Cardiovascular Outcomes According to Renal Function in Patients Treated With Once-Weekly Exenatide: Insights From the EXSCEL Trial
    Bethel, M. Angelyn
    Mentz, Robert J.
    Merrill, Peter
    Buse, John B.
    Chan, Juliana C.
    Goodman, Shaun G.
    Iqbal, Nayyar
    Jakuboniene, Neli
    Katona, Brian
    Lokhnygina, Yuliya
    Lopes, Renato D.
    Maggioni, Aldo P.
    Ohman, Peter
    Tankova, Tsvetalina
    Bakris, George L.
    Hernandez, Adrian F.
    Holman, Rury R.
    DIABETES CARE, 2020, 43 (02) : 446 - 452
  • [6] Rationale and design of the EXenatide Study of Cardiovascular Event Lowering (EXSCEL) trial
    Holman, Rury R.
    Bethel, Mary Angelyn
    George, Jyothis
    Sourij, Harald
    Doran, Zoe
    Keenan, Joanne
    Khurmi, Nardev S.
    Mentz, Robert J.
    Oulhaj, Abderrahim
    Buse, John B.
    Chan, Juliana C.
    Iqbal, Nayyar
    Kundu, Sudeep
    Maggioni, Aldo P.
    Marso, Steven P.
    Oehman, Peter
    Pencina, Cmichael J.
    Poulter, Neil
    Porter, Lisa E.
    Ramachandran, Ambady
    Zinman, Bernard
    Hernandez, Adrian F.
    AMERICAN HEART JOURNAL, 2016, 174 : 103 - 110
  • [7] Effects of once-weekly exenatide on clinical outcomes in the subgroup of patients with pre-existing cardiovascular disease: insights from EXSCEL
    Mentz, R. J.
    Thompson, V. P.
    Gustavson, S. M.
    Iqbal, N.
    Ohman, P.
    Holman, R. R.
    Hernandez, A. F.
    EUROPEAN HEART JOURNAL, 2018, 39 : 1082 - 1082
  • [8] Effects of Once-Weekly Exenatide on Clinical Outcomes in Patients With Preexisting Cardiovascular Disease: Prespecified Analysis From EXSCEL
    Mentz, Robert J.
    Thompson, Vivian P.
    Aguilar, David
    Choi, Jasmine
    Gustavson, Stephanie M.
    Iqbal, Nayyar
    Kong, Alice P.
    Ohman, Peter
    Sattar, Naveed
    Scott, Russell S.
    Wong, Yee Weng
    Holman, Rury R.
    Hernandez, Adrian F.
    CIRCULATION, 2018, 138 (22) : 2576 - 2578
  • [9] Baseline Characteristics of Patients Enrolled in the Exenatide Study of Cardiovascular Event Lowering (EXSCEL)
    Mentz, Robert
    Bethel, M. Angelyn
    Gustavson, Stephanie
    Thompson, Vivian
    Buse, John B.
    Chan, Juliana
    Maggioni, Aldo P.
    Marso, Steven P.
    Ohman, Peter
    Poulter, Neil
    Ramachandran, Ambady
    Zinman, Bernard
    Iqbal, Nayyar
    Hernandez, Adrian F.
    Holman, Rury R.
    DIABETES, 2016, 65 : A271 - A271
  • [10] Baseline characteristics of patients enrolled in the Exenatide Study of Cardiovascular Event Lowering (EXSCEL)
    Mentz, Robert J.
    Bethel, M. Angelyn
    Gustavson, Stephanie
    Thompson, Vivian P.
    Pagidipati, Neha J.
    Buse, John B.
    Chan, Juliana C.
    Iqbal, Nayyar
    Maggioni, Aldo P.
    Marso, Steve P.
    Ohman, Peter
    Poulter, Neil
    Ramachandran, Ambady
    Zinman, Bernard
    Hernandez, Adrian F.
    Holman, Rury R.
    AMERICAN HEART JOURNAL, 2017, 187 : 1 - 9
12345